Skip to content
10-Q

Quarterly Report

INTEC PHARMA LTD.

0001213900-20-035149

← back to feed
Filed
Nov 5, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 5, 2020 3.95M sh
Capex Q3 2020 · Sep 30, 2020 $16K
Capex Q3 2020 · Sep 30, 2019 $791K
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$8.86M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$23.92M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $17.08M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $9.29M
Cash And Equivalents Q3 2020 · Sep 30, 2019 $14.97M
Cash And Equivalents Q3 2020 · Dec 31, 2018 $39.25M
Stockholders Equity Q3 2020 · Sep 30, 2020 $18.08M
Stockholders Equity Q3 2020 · Jun 30, 2020 $16.18M
Stockholders Equity Q3 2020 · Dec 31, 2019 $11.54M
Stockholders Equity Q3 2020 · Sep 30, 2019 $17.49M
Stockholders Equity Q3 2020 · Jun 30, 2019 $35.11M
Stockholders Equity Q3 2020 · Dec 31, 2018 $53.55M
Current Liabilities Q3 2020 · Sep 30, 2020 $4.55M
Current Liabilities Q3 2020 · Dec 31, 2019 $8.34M
Total Liabilities Q3 2020 · Sep 30, 2020 $5.96M
Total Liabilities Q3 2020 · Dec 31, 2019 $9.75M
Current Assets Q3 2020 · Sep 30, 2020 $17.69M
Current Assets Q3 2020 · Dec 31, 2019 $13.75M
Total Assets Q3 2020 · Sep 30, 2020 $24.04M
Total Assets Q3 2020 · Dec 31, 2019 $21.28M
Sga Expense Q3 2020 · Sep 30, 2020 $1.53M
Sga Expense Q3 2020 · Sep 30, 2020 $4.87M
Sga Expense Q3 2020 · Sep 30, 2019 $2.16M
Sga Expense Q3 2020 · Sep 30, 2019 $6.49M
Rd Expense Q3 2020 · Sep 30, 2020 $2.11M
Rd Expense Q3 2020 · Sep 30, 2020 $5.41M
Rd Expense Q3 2020 · Sep 30, 2019 $8.45M
Rd Expense Q3 2020 · Sep 30, 2019 $24.85M
Net Income Q3 2020 · Sep 30, 2020 −$3.74M
Net Income Q3 2020 · Sep 30, 2020 −$10.56M
Net Income Q3 2020 · Sep 30, 2019 −$20.38M
Net Income Q3 2020 · Sep 30, 2019 −$41.04M
Operating Income Q3 2020 · Sep 30, 2020 −$3.64M
Operating Income Q3 2020 · Sep 30, 2020 −$10.29M
Operating Income Q3 2020 · Sep 30, 2019 −$20.36M
Operating Income Q3 2020 · Sep 30, 2019 −$41.1M